ICON Company Description
By the time a new drug hits the market, it has passed through a series of clinical trials to make it safe and effective; guiding drugs through that process is what ICON does best. The contract research organization (CRO) provides drugmakers and medical device companies around the world with a broad range of services for their product candidates' clinical trials. ICON designs studies and recruits investigators; manages and analyzes trial data; writes reports and other documents; and assists with regulatory filings. It also helps with preclinical drug development and with post-approval safety monitoring. The firm has operations in more than 35 countries around the world.
View the Comprehensive Company Description for ICON
The Company Description provides a historical perspective of ICON's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of ICON's evolution in the marketplace.
